A multi-center phase 3, open-label, parallel group study to evaluate the efficacy, safety and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and varying degrees of renal impairment
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2013
At a glance
- Drugs Adefovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 15 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2005 New trial record.